NO ADVERSE EVENT

This adverse event was reported 102334 times

These drugs are most commonly taken by patients reporting NO ADVERSE EVENT:

# Drug Count
0 ETONOGESTREL 8864
1 METHYLPHENIDATE 6603
2 MOMETASONE FUROATE 3027
3 OMALIZUMAB 2919
4 TOCILIZUMAB 2813
5 ALBUTEROL SULFATE 2691
6 MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE 2657
7 RITUXIMAB 1786
8 SACUBITRIL AND VALSARTAN 1501
9 VEDOLIZUMAB 1370
See all common drugs associated with NO ADVERSE EVENT

NO ADVERSE EVENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DILUENT 667 0.6469
1 RUBIDIUM CHLORIDE RB-82 56 0.6154
2 IOBENGUANE I-123 34 0.5862
3 TESTOSTERONE GEL, 1% 66 0.5789
4 IOFLUPANE I-123 176 0.5350
5 TETROFOSMIN 228 0.4989
6 RIBOFLAVIN 5-PHOSPHATE IN 20% DEXTRAN OPHTHALMIC 42 0.3111
7 RIBOFLAVIN 5-PHOSPHATE OPHTHALMIC 28 0.2979
8 BALOXAVIR MARBOXIL 403 0.2597
9 PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF 23 0.2323
See all drugs enriched for association with NO ADVERSE EVENT

NO ADVERSE EVENT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] 304 0.2262
1 Radioactive Diagnostic Agent [EPC] 227 0.2056
2 Cholecystokinin Analog [EPC] 21 0.1500
3 Gonadotropin [EPC] 103 0.0897
4 Lead Chelator [EPC] 4 0.0741
5 Estrogen Agonist/Antagonist [EPC] 173 0.0687
6 Recombinant Antithrombin [EPC] 1 0.0625
7 Interferon alfa-2b [EPC] 2 0.0606
8 Anti-IgE [EPC] 2919 0.0599
9 Skin Test Antigen [EPC] 107 0.0545
See all drug classes enriched for association with NO ADVERSE EVENT